Lumida
/HLF
⌘K
Herbalife Ltd

Herbalife Ltd

HLF
$12.02USD-2.12%-0.26 today

MARKET CAP

1.3B

P/E (TTM)

5.2x

FWD P/E

DAY RANGE

$12 – $13

52W RANGE

$8
$20

AI Summary

Stalk
TrimMedium

HLF is consolidating near recent lows under declining long-term moving averages, indicating that supply remains dominant and upside conviction is lacking. With price below the 50- and 200-day averages and no active reversal patterns, the medium-term bias is bearish. Execution should be deferred: focus on selling into rallies toward the EMA/50 DMA cluster and the 200-day SMA, watching for rejection and normalized volume to confirm supply. A sustained breakout above these averages on strength would invalidate the bearish thesis and require reevaluation.

  • Net sales +5.4% YoY to $1.3B in Q2, fourth consecutive growth
  • FCF yield >23% with $147M operating cash flow in H1 2026
  • Net loss $26M in Q2 due to debt extinguishment, underscoring profitability strain
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$5.8B$5.2B$5.1B$5.0B$5.0B
YoY %+4.7%-10.2%-2.6%-1.4%+0.8%
P / Sales0.8x0.3x0.3x0.1x0.3x
EV / Sales1.4x1.0x1.0x0.8x0.8x
Gross Profit, Adj.$4.6B$4.0B$3.9B$3.9B$3.9B
YoY %+3.9%-11.5%-3.8%+0.5%+0.8%
Margin %78.6%77.5%76.5%77.9%77.9%
EV / Gross Profit1.8x1.2x1.2x1.0x1.1x
EBITDA, Adj.$841.7M$666.7M$471.0M$514.1M$605.9M
YoY %+13.6%-20.8%-29.4%+9.2%+17.9%
Margin %14.5%12.8%9.3%10.3%12.0%
EV / EBITDA9.6x7.5x10.3x7.4x7.1x
EBIT$734.1M$551.3M$357.7M$392.7M$484.7M
YoY %+14.6%-24.9%-35.1%+9.8%+23.4%
Margin %12.7%10.6%7.0%7.8%9.6%
EV / EBIT11.0x9.0x13.5x9.7x8.8x
Net Income$447.2M$321.3M$142.2M$254.3M$228.3M
YoY %+20.0%-28.2%-55.7%+78.8%-10.2%
Net Margin7.7%6.2%2.8%5.1%4.5%
EPS (GAAP)$4.13$3.23$1.42$2.50$2.20
YoY %+49.1%-21.8%-56.0%+76.1%-12.0%